Chapter
Preconditioning in Lung Transplantation
Ischaemic Conditioning and Remote Ischaemic Conditioning
Evidence in Lung Transplantation
Intensive Care Management of Lung Transplant Recipient
Paolo Feltracco*, Eugenio Serra, Stefania Barbieri, Moira Milevoj, and Carlo Ori
Department of Anesthesia and Intensive Care, University Hospital of Padova,
Physiology of the Transplanted Graft
Postoperative Hemodynamic Assessment and Stabilization
Fluid Management and Volumetric Monitoring
Primary Graft Dysfunction
Postoperative Management of Ventilation
Weaning from Mechanical Ventilation
Postoperative Pain Control
Acute Postoperative Physical Rehabilitation
Postoperative Renal Complications
Gastrointestinal (GI) Complications
Impact of Viral Pathogens in Lung Transplant Recipients
Cristina Costa1*, Massimiliano Bergallo1, Paolo Solidoro2, Sergio Baldi2, and Rossana Cavallo1
1Virology Unit, and 2Pulmonary Division; University Hospital S. Giovanni Battista di Torino. Via Santena 9 – 10126 Turin, Italy
Community Acquired Respiratory Viruses
Paramyxoviridae (Parainfluenzaviruses, Respiratory Syncytial Virus, Human Metapneumovirus)
Persistently Infecting Viruses: The Herpesviridae Family
Role of Β-Herpesviruses and Epstein-Barr Virus in the Lower Respiratory Tract From Lung Transplant Patients: Results of a Study Performed at the Virology Unit of the University Hospital San Giovanni Battista, Turin, Italy
Identification of Allo- and Auto-Antibodies after Lung Transplantation
A.W.M. Paantjens1*, E.A. van de Graaf2, J.M. Kwakkel-van Erp2, W.G.J. van Ginkel1, T. Hoefnagel1, D.A. van Kessel3, J.M.M. van den Bosch3, and H.G. Otten1
3 Academic Medical Centre Utrecht and Pulmonology
Sint Antonius Ziekenhuis Nieuwegein, The Netherlands
The Bronchiolitis Obliterans Syndrome After Lung Transplantation
Antibody Mediated Rejection
Serological Proteome Analysis
Stem Cell Transplantation
Surgical Aspects of Lung Transplantation
Silvana Marasco 2, Adrian Pick1
1 Cardiothoracic Surgical Unit, The Alfred Hospital, Melbourne, Australia
2 Department of Surgery, Monash University, Australia
Bilateral Anterolateral Thoracotomy
Anterior Axillary Muscle Sparing Thoracotomy
Posterolateral Thoracotomy
Bronchial Anastomotic Techniques
Pulmonary Vascular Anastomoses
Back Table versus In Situ Lobectomy
Choosing which Lobe to Resect
Choosing How Much Lung to Resect
Neurologic Complications of Lung Transplantation
VA Pittsburgh HCS and University of Pittsburgh
2. Neurologic Complications of Organ Transplantation
3. Neurologic Complications of Lung Transplantation
3.1. Disorders of Consciousness and Behavior
3.3. Cerebrovascular Complications
3.4. Neuromuscular Complications
3.5 Immunosuppressant Neurotoxicity
3.6. Opportunistic Infections
3.7. Other Neurologic Complications
Leucocyte Intracellular Cytokines
in Lung Transplant Patients - A More Physiological Indicator of Immunosuppression than Plasma Drug Levels
Greg Hodge1,2, Sandra Hodge1, Paul Reynolds1, Daniel Chambers3 and Mark Holmes1,4
Acute and Chronic Transplant Rejection
Calcineurin Inhibitors: Cyclosporin A (CsA) and Tacrolimus (Tac)
Antimetabolites: Azathioprine and Mycophenolate Mofetil
Anti-lymphocyte Antibodies
Anti-cytokine Receptor Antibodies
Cytokine Measurement in Lung Transplant Patients
Effect of Immunosuppression Protocols on Intracellular Cytokines in Blood T Cells
Effect of Immunosuppression Protocols on Blood Monocyte Cytokine and Chemokine Production
Effect of Current Immunosuppression Protocols on Intracellular Pro- and Anti-inflammatory Cytokines in Bronchoalveolar Lavage T Cells of Stable Lung Transplant Patients
Effect of Current Immunosuppression Protocols on Intracellular pro-Inflammatory Cytokines in Bronchial intra-epithelial T Cells of Stable Lung Transplant Patients
Airway Infection is Associated with Increased Immunosuppression of Intracellular Th1 Cytokines in Bronchoalveolar Lavage CD8+ T Cells Compared with Stable Lung Transplant Patients
Longitudinal Monitoring of Immunosuppression in Transplant Patients by Measurement of Intracellular T Cell Cytokines
Analysis of Intracellular Cytokines to Improve Therapeutic Immunosuppression Monitoring Following Lung Transplantation Now and in the Future
Measurement of Intracellular Cytokines to Improve Therapeutic Monitoring of Immunosuppressive Drugs Following Lung Transplantation
Greg Hodge1,2, Sandra Hodge1, Paul Reynolds1 and Mark Holmes1
1 Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide;
2 Haematology Department, Women’s and Children’s Hospital,
North Adelaide, South Australia;
Calcineurin Inhibitors: Cyclosporin A (CsA) and Tacrolimus (Tac)
Antimetabolites: Azathioprine (AZA) and Mycophenolate Mofetil (MMF)
Anti-Lymphocyte Antibodies
Anti-Cytokine Receptor Antibodies
Measurement of Inflammatory Cytokines in Transplant Patients
Effect of Immunosuppression Protocols on Intracellular Cytokines in Blood T Cells
Effect of Immunosuppression Protocols on Blood Monocyte Intracellular Cytokine and Chemokine Production
Increased Intracellular Pro- and Anti-Inflammatory Cytokines in Bronchoalveolar Lavage T Cells of Stable Lung Transplant Patients
Compartmentalisation of Intracellular
Pro-Inflammatory Cytokines in Bronchial
Intra-Epithelial T Cells of Stable
Airway Infection Is Associated with Decreased Intracellular Th1 Cytokines in Bronchoalveolar Lavage CD8+ T Cells of Stable Lung
Longitudinal Monitoring of Intracellular T Cell Cytokines in Transplant Patients
Future of Intracellular Cytokines to Improve Therapeutic Monitoring Following Lung Transplantation
Lung Transplantation: Therapies, Complications and Outcomes
( Organ Transplantation Research Horizons )
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.